http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-930021788-A
Outgoing Links
| Predicate | Object |
|---|---|
| filingDate | 1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-930021788-A |
| titleOfInvention | TNF-mutein |
| abstract | Human tumors with selective binding affinity for human p55-tumor-necrosis-factor-receptor characterized in that the amino acid sequence of human tumor necrosis factor is changed at least at 86 to represent threonine residues instead of serine residues Necrosis factor muteins or pharmaceutically acceptable salts thereof, DNA sequences encoding said muteins, vectors comprising said DNA sequences, host cells transformed with said vectors, production of said muteins by said host cells A method, a pharmaceutical composition comprising said mutein, and a use of said mutein for a disease. |
| priorityDate | 1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396493 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7124 |
Total number of triples: 10.